Ivan Klyuzhin, PhD
Chief Executive Officer &
Co-Founder
Elevating cancer care with
Ascinta Technologies advances precision medicine with cutting-edge software and expert services in theranostics and quantitative nuclear imaging — supporting drug developers, CROs, clinics, and academic groups.
We help develop and deliver the next generation of diagnostic and therapeutic solutions.
Fully managed, ongoing theranostic workflows and patient-specific dosimetry — PACS monitoring, validated pipelines, and physician-ready reports, all on-premises.
Learn more → 02Detail-oriented image quantification and dosimetry for theranostic trials and research, across established and emerging radionuclides.
Learn more → 03Fractional medical physics expertise — protocol design, quality control, calibration, and focused analysis — scaled to what you need.
Learn more →We offer specialized expertise supporting the full theranostic workflow
— from protocol design to quantification and reporting.
Manual and automated workflows for medical image reconstruction, processing, and quantification.
A legacy in quantitative nuclear imaging and therapy, AI-driven image computing, and theranostics — combining scientific knowledge with clinical insight.
Chief Executive Officer &
Co-Founder
Chief Scientific Officer &
Co-Founder
Chair of the Board &
Co-Founder
Chief Product Officer
Every engagement is backed by medical physicists specialized in quantitative imaging and dosimetry.
Our methods are rooted in scientific evidence and follow MIRD and ICRP guidelines.
Multi-method comparison and documented uncertainty keep your results accurate and reproducible.
Fully managed, project-based, or on-demand — scale support up or down without hiring.
Interested in our products and services? Send us a message and we'll get in touch.
*We'll never send spam or share your contact info.
Ascinta Technologies Inc.